NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ·Healthcare·Biotechnology
$18.59
-1.64%
Mkt Cap $2.29B
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (14 analysts)
$51.33
Range $45.00 – $58.00
Implied Upside
+176.1%
Consensus $51.33 vs current $18.59